Article Contents ::
- 1 The Brand Name MOBRINE IR Has Generic Salt :: CYCLOBENZAPRINE
- 2 MOBRINE IR Is From Company Ranbaxy Priced :: Rs. 90
- 3 MOBRINE IR have CYCLOBENZAPRINE is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name MOBRINE IR Has Generic Salt :: CYCLOBENZAPRINE
MOBRINE IR Is From Company Ranbaxy Priced :: Rs. 90
MOBRINE IR have CYCLOBENZAPRINE is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| CYCLOBENZAPRINE | TAB | Rs. 90 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| MOBRINE IR | Ranbaxy | 10MG | 10 | Rs. 90 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Ranbaxy :: MOBRINE IR | CYCLOBENZAPRINE | #N/A | #N/A |
Indications for Drugs ::
Fibromyalgia, Muscle spasm
Drug Dose ::
Adult: PO 5 mg 3 times/day for not >2-3 wk. May increase to 10 mg 3 times/day if needed.
Contraindication ::
Recent MI, arrhythmias, severe liver disease.
Drug Precautions ::
Cardiac disease, history of epilepsy, hepatic impairment, hyperthyroidism, pheochromocytoma, history of mania, psychoses, close-angle glaucoma, history of urinary retention, concurrent electroconvulsive therapy, diabetes. Pregnancy and lactation; elderly, child. Unsafe for use in patients with porphyria. Avoid abrupt withdrawal. May cause drowsiness; do not drive or operate machinery. Treatment for more than 2-3 wk is not recommended.
Drug Side Effects ::
Antimuscarinic effects, neurological adverse effects, GI disorders, orthostatic hypotension, tachycardia, hypersensitivity reactions. Rarely, cholestatic jaundice and blood disorders. Endocrine effects, sexual dysfunction, changes in blood sugar. Increased appetite with wt gain, sweating.
Pregnancy category ::
2
Drug Mode of Action ::
Cyclobenzaprine, a centrally-acting skeletal muscle relaxant, is structurally related to tricyclic antidepressants, thus they share similar properties. It acts on the brain stem, decreasing tonic-somatic motor activities influencing both the ? and ? motor systems. It is used as an adjunct in the symptomatic treatment of painful muscle spasms associated with musculoskeletal conditions.
Drug Interactions ::
Plasma concentration may be increased with the use of cimetidine, diltiazem, disulfiram, methylphenidate, ritonavir, and verapamil. Side-effects are increased by adrenaline, amiodarone, general anesthetics, SSRIs, antihistamines, antimuscarinics, antipsychotics, anxiolytics and hypnotics, clozapine, disopyramide, diuretics, flecainide, MAOIs, moclobemide, moxifloxacin, nefopam, nicorandil, noradrenaline, phenothiazine, pimozide, procainamide, propafenone, quinidine, selegiline, sibutramine, sotalol, terfenadine, thioridazine, and tramadol. Effects of adrenergic neurone blockers, clonidine, barbiturates, nitrates, and primidone are reduced while effects of baclofen, opioid analgesics, and thyroid hormones are enhanced with concomitant use of cyclobenzaprine. Carbamazepine and rifampicin may increase metabolism of cyclobenzaprine. Effects may be antagonized by oestrogens. Avoid use with brimonidine, entacapone, artemether with lumefantrine, or sibutramine. CNS effects may be enhanced by other CNS depressants.
